SOUTH KOREA · OPENDART
Xcell Therapeutics Inc.
엑셀세라퓨틱스 · 373110 · KOSDAQ · Healthcare · Biotechnology
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insiders' buying price vs the latest close
Insiders paid 1,455.39 KRW a share on average (11 purchase lines, 5 buyers, 2026-02-06 – 2026-03-30). The close on 2026-10-16 was 19.7% below that price.
The latest purchase (2026-03-30) was at 1,414.56 KRW; the close was 17.4% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
| Trade date | Insider | Role | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-30 | Jeong Hae min | Senior managing director | Bought on the exchange | 2,500 | ₩1,434 | ₩3.6M | DART ↗ |
| 2026-03-30 | KIM JONG WAN | Managing director | Bought on the exchange | 5,080 | ₩1,405 | ₩7.1M | DART ↗ |
| 2026-03-27 | KIM JONG WAN | Managing director | Bought on the exchange | 2,000 | ₩1,420 | ₩2.8M | DART ↗ |
| 2026-03-26 | Oh Soo Lim | Vice president | Bought on the exchange | 2,000 | ₩1,457 | ₩2.9M | DART ↗ |
| 2026-03-25 | Oh Soo Lim | Vice president | Bought on the exchange | 8,000 | ₩1,442 | ₩11.5M | DART ↗ |
| 2026-03-25 | LEE WOON | Senior managing director | Bought on the exchange | 6,980 | ₩1,477 | ₩10.3M | DART ↗ |
| 2026-03-25 | KIM YOON SHIN | Managing director | Bought on the exchange | 3,437 | ₩1,455 | ₩5.0M | DART ↗ |
| 2026-03-16 | KIM YOON SHIN | Managing director | Bought on the exchange | 74 | ₩1,359 | ₩100,566 | DART ↗ |
| 2026-03-13 | KIM YOON SHIN | Managing director | Bought on the exchange | 3,526 | ₩1,416 | ₩5.0M | DART ↗ |
| 2026-02-10 | Oh Soo Lim | Vice president | Bought on the exchange | 2,000 | ₩1,614 | ₩3.2M | DART ↗ |
| 2026-02-06 | Oh Soo Lim | Vice president | Bought on the exchange | 1,000 | ₩1,619 | ₩1.6M | DART ↗ |
Other changes in holdings · 10
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2026-03-27 | Jung Hae-min | Senior managing director | New appointment(+) | 4,500 | DART ↗ |
| 2025-11-21 | Uri Lee | CEO | Others(-) | 299,752 | DART ↗ |
| 2025-11-21 | Uri Lee | CEO | Acquisition of paid-in new shares(+) | 299,752 | DART ↗ |
| 2025-11-04 | Joo youn Lee | Senior managing director | Disposal in exchange(-) | 5,134 | DART ↗ |
| 2025-11-03 | Joo youn Lee | Senior managing director | Disposal in exchange(-) | 3,000 | DART ↗ |
| 2025-10-30 | Uri Lee | CEO | Disposal in exchange(-) | 237,092 | DART ↗ |
| 2025-10-27 | Uri Lee | CEO | Disposal in OTC(-) | 462,330 | DART ↗ |
| 2025-10-21 | Uri Lee | CEO | Others(+) | 999,174 | DART ↗ |
| 2025-10-21 | Joo youn Lee | Senior managing director | Others(+) | 8,134 | DART ↗ |
| 2025-01-08 | Joo youn Lee | Senior managing director | 주식매수선택권(+) | 14,000 | DART ↗ |